Biotech

All Articles

Takeda taps new head of US oncology company-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings ...

Vertex, hammered by AATD once more, falls 2 assets on throw away stack

.Vertex's try to address a rare hereditary ailment has actually struck one more misfortune. The biot...

Vir gains 3 T-cell engagers from Sanofi, gives up 25% of personnel

.Vir Medical's second-quarter earnings report had not been except major information. The company inv...

Galapagos stops CAR-T tissue treatment litigation over Parkinsonism case

.Galapagos has actually stopped enrollment in a trial of a BCMA-directed CAR-T cell treatment, pumpi...

James Wilson leaving Penn to launch two brand new biotechs

.After much more than three decades, genetics treatment pioneer James Wilson M.D., Ph.D., is actuall...

3 biotechs make an effort to defeat the summertime warmth through shedding personnel

.As biotechs try to transform a fresh page in August, a minimum of three providers have lost workers...

venBio lifts $528M for 5th life scientific researches VC fund

.Expert venture capital agency venBio has actually raised one more half a billion dollars to acquire...

Otsuka pays for $800M for Jnana and also its own clinical-stage PKU medication

.Otsuka Drug has picked up Boston-based Jnana Therapeutics for $800 million so the Japanese biotech ...

FibroGen gives up 75% people personnel as asset flunks 2 more trials

.FibroGen is actually substantially reorganizing its own service, giving up 75% of its united state ...

Tracon winds down weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has actually decided to unwind operations weeks after an injectable invulner...